Avance Clinical

Avance Clinical is a full-service Contract Research Organization (CRO) headquartered in Australia, with extensive operations across New Zealand, Asia, North America, and Europe. As the market leaders in early phase clinical trials, we leverage the unique advantages of the Australian market, including rapid ethics approval, no IND requirement, and the 43.5% R&D tax rebate, to provide biotechs with an accelerated pathway to clinical success. Specializing in world-class operations, we guide biotechs from early pre-clinical development through to late-phase studies. With a focus on agility, innovation, and cost-effectiveness, we deliver fast results backed by robust, globally accepted data. With expertise spanning over 250+ indications, across all therapeutic areas, over the last three decades, Avance Clinical consistently delivers data recognized by key global regulators, including the TGA, FDA, EMA, MHRA, MFDS, and PDMA. What sets us apart is our personalized service tailored to each client, ensuring customized, flexible solutions rather than a one-size-fits-all approach. www.avancecro.com

Website

http://www.avancecro.com/

External link for Avance Clinical

Industry

Biotechnology Research

Company size

201-500 employees

Headquarters

Firle, SOUTH AUSTRALIA

Type

Privately Held

Founded

2019

Specialties

Full service CRO, Preclinical & Early Phase Clinical Trials, Late Phase Clinical Trials, ClinicReady, GlobalReady, Biotech Clinical Trials, 120+ Therapeutic Indications, Rare Diseases, Oncology, Central Nervous System, Infectious Diseases, and Cell & Gene Therapies